Navidea highlights research on melanoma, oral cancer
Radiopharmaceutical developer Navidea Biopharmaceuticals is directing attentio...Read more on AuntMinnie.comRelated Reading:
Navidea touts clinical study using PET/CT for HIV infection
Navidea touts early results of RA study
Navidea secures Indian regulatory approval for Lymphoseek
NYSE accepts Navidea bid to comply with stock listing rules
Navidea reports revenue declines in Q4, all of 2021
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | India Health | Melanoma | Oral Cancer | Radiology | Skin Cancer | Study